Novel and potent cyclic cyanamide-based cathepsin K inhibitors
David N. Deaton, Anne M. Hassell, Robert B. McFadyen et al. · Bioorganic & Medicinal Chemistry Letters · 2005
Cited by 42 works. doi:10.1016/j.bmcl.2005.02.033
Authors
- David N. Deaton
- Anne M. Hassell
- Robert B. McFadyen
- Aaron B. Miller
- Larry R. Miller
- Lisa M. Shewchuk
- Francis X. Tavares
- Derril H. Willard
- Lois L. Wright
References
- Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency
- Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L
- Polypeptides. Part XIII. Preparation of α-aza-amino-acid (carbazic acid) derivatives and intermediates for the preparation of α-aza-peptides
- Potent and Selective Inhibition of Human Cathepsin K Leads to Inhibition of Bone Resorption In Vivo in a Nonhuman Primate
- Collagenase Activity of Cathepsin K Depends on Complex Formation with Chondroitin Sulfate
- Total synthesis of mugineic acid. Efficient use of the phenyl group as the carboxyl synthon
- Homochiral Proline N-Oxides as Conformational Constraints in Peptide Like Molecules
- A synthetic route to the tricarbonyl region of FK-506
- Theoretical Analysis of Lewis Basicity Based on Local Electron-Donating Ability. Origin of Basic Strength of Cyclic Amines
- Cathepsin K Inhibitors: Their Potential as Anti-Osteoporosis Agents